The JAK2 V617F mutation is rare in RARS but common in RARS-T

被引：55

作者：

Ceesay, M. M. ^{[1
]}

Lea, N. C.

Ingram, W.

Westwood, N. B.

Gaken, J.

Mohamedali, A.

Cervera, J.

Germing, U.

Gallermann, N.

Giagounidis, A.

Garcia-Casado, Z.

Sanz, G.

Mufti, G. J.

机构：

[1] Kings Coll London, Dept Haematol Med, London WC2R 2LS, England

[2] Hosp Univ Fe, Serv Hematol & Hemoterpia, Valencia, Spain

[3] Univ Dusseldorf, Dept Haematol Oncol & Clin Immunol, D-4000 Dusseldorf, Germany

[4] St Johannes Hosp, Dept Oncol & Clin Immunol, Duisburg, Germany

来源：

LEUKEMIA | 2006年 / 20卷 / 11期

关键词：

D O I：

10.1038/sj.leu.2404373

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2060 / 2061

页数：3

共 7 条

[1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].

Baxter, EJ ;

Scott, LM ;

Campbell, PJ ;

East, C ;

Fourouclas, N ;

Swanton, S ;

Vassiliou, GS ;

Bench, AJ ;

Boyd, EM ;

Curtin, N ;

Scott, MA ;

Erber, WN ;

Green, AR .

LANCET, 2005, 365 (9464) :1054-1061

[2] The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow [J].

Ingram, W. ;

Lea, N. C. ;

Cervera, J. ;

Germing, U. ;

Fenaux, P. ;

Cassinat, B. ;

Kiladjian, J. J. ;

Varkonyi, J. ;

Antunovic, P. ;

Westwood, N. B. ;

Arno, M. J. ;

Mohamedali, A. ;

Gaken, J. ;

Kontou, T. ;

Czepulkowski, B. H. ;

Twine, N. A. ;

Tamaska, J. ;

Csomer, J. ;

Benedek, S. ;

Gattermann, N. ;

Zipperer, E. ;

Giagounidis, A. ;

Garcia-Casado, Z. ;

Sanz, G. ;

Mufti, G. J. .

LEUKEMIA, 2006, 20 (07) :1319-1321

[3]

Jaffe ES., 2001, PATHOLOGY GENETICS T

[4] Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome [J].

Patel, Raj K. ;

Lea, Nicholas C. ;

Heneghan, Michael A. ;

Westwood, Nigel B. ;

Milojkovic, Dragana ;

Thanigaikumar, Murugaiyan ;

Yallop, Deborah ;

Arya, Roopen ;

Pagliuca, Antonio ;

Gaken, Joop ;

Wendon, Julia ;

Heaton, Nigel D. ;

Mufti, Ghulam J. .

GASTROENTEROLOGY, 2006, 130 (07) :2031-2038

[5]

Remacha AF, 2006, HAEMATOLOGICA, V91, P719

[6] The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes [J].

Steensma, DP ;

Dewald, GW ;

Lasho, TL ;

Powell, HL ;

McClure, RF ;

Levine, RL ;

Gilliland, DG ;

Tefferi, A .

BLOOD, 2005, 106 (04) :1207-1209

[7]

SZPURKA H, 2006, BLOOD 0601

← 1 →